185 related articles for article (PubMed ID: 31986971)
1. The Influence of Vestibular Schwannoma Tumor Volume and Growth on Hearing Loss.
Patel NS; Huang AE; Dowling EM; Lees KA; Tombers NM; Lohse CM; Marinelli JP; Van Gompel JJ; Neff BA; Driscoll CLW; Link MJ; Carlson ML
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):530-537. PubMed ID: 31986971
[TBL] [Abstract][Full Text] [Related]
2. Rate of Initial Hearing Loss During Early Observation Predicts Time to Non-Serviceable Hearing in Patients With Conservatively Managed Sporadic Vestibular Schwannoma.
Carlson ML; Dowling EM; Lohse CM; O'Connell BP; Driscoll CLW; Haynes DS; Link MJ; Hunter JB
Otol Neurotol; 2019 Dec; 40(10):e1012-e1017. PubMed ID: 31634279
[TBL] [Abstract][Full Text] [Related]
3. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
4. Hearing loss and volumetric growth rate in untreated vestibular schwannoma.
Gurewitz J; Schnurman Z; Nakamura A; Navarro RE; Patel DN; McMenomey SO; Roland JT; Golfinos JG; Kondziolka D
J Neurosurg; 2022 Mar; 136(3):768-775. PubMed ID: 34416729
[TBL] [Abstract][Full Text] [Related]
5. Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients With Serviceable Hearing.
Hunter JB; Dowling EM; Lohse CM; O'Connell BP; Tombers NM; Lees KA; Thompson RS; Haynes DS; Carlson ML
Otol Neurotol; 2018 Sep; 39(8):e704-e711. PubMed ID: 30036205
[TBL] [Abstract][Full Text] [Related]
6. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
[TBL] [Abstract][Full Text] [Related]
7. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
[TBL] [Abstract][Full Text] [Related]
8. Conservative management of vestibular schwannoma: Predictors of growth and hearing.
Jethanamest D; Rivera AM; Ji H; Chokkalingam V; Telischi FF; Angeli SI
Laryngoscope; 2015 Sep; 125(9):2163-8. PubMed ID: 25647714
[TBL] [Abstract][Full Text] [Related]
9. Durability of Hearing Preservation Following Microsurgical Resection of Vestibular Schwannoma.
Dowling EM; Patel NS; Lohse CM; Driscoll CLW; Neff BA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2019 Dec; 40(10):1363-1372. PubMed ID: 31725593
[TBL] [Abstract][Full Text] [Related]
10. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
11. Tumor growth rate: A new prognostic indicator of hearing preservation in vestibular schwannoma surgery.
Lovato A; García Ibañez E; García Ibañez L; de Filippis C
Laryngoscope; 2019 Oct; 129(10):2378-2383. PubMed ID: 30623429
[TBL] [Abstract][Full Text] [Related]
12. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
14. Hearing preservation after middle fossa vestibular schwannoma removal: are the results durable?
Quist TS; Givens DJ; Gurgel RK; Chamoun R; Shelton C
Otolaryngol Head Neck Surg; 2015 Apr; 152(4):706-11. PubMed ID: 25628370
[TBL] [Abstract][Full Text] [Related]
15. Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial.
Saraf A; Pike LRG; Franck KH; Horick NK; Yeap BY; Fullerton BC; Wang IS; Abazeed ME; McKenna MJ; Mehan WA; Plotkin SR; Loeffler JS; Shih HA
Neurosurgery; 2022 May; 90(5):506-514. PubMed ID: 35229827
[TBL] [Abstract][Full Text] [Related]
16. Ten-Year Follow-up on Tumor Growth and Hearing in Patients Observed With an Intracanalicular Vestibular Schwannoma.
Kirchmann M; Karnov K; Hansen S; Dethloff T; Stangerup SE; Caye-Thomasen P
Neurosurgery; 2017 Jan; 80(1):49-56. PubMed ID: 27571523
[TBL] [Abstract][Full Text] [Related]
17. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
18. Automated Whole Cochlear T2 Signal Demonstrates Weak Correlation with Hearing Loss in Observed Vestibular Schwannoma.
Cass ND; Fan Y; Lindquist NR; Dawant BM; Tawfik KO
Audiol Neurootol; 2023; 28(5):394-404. PubMed ID: 37321181
[TBL] [Abstract][Full Text] [Related]
19. Vestibular Schwannomas: Do Linear and Volumetric Parameters on MRI Correlate With Hearing Loss?
Bathla G; Case BM; Berbaum K; Hansen MR; Policeni B
Otol Neurotol; 2016 Sep; 37(8):1168-73. PubMed ID: 27466888
[TBL] [Abstract][Full Text] [Related]
20. Progression of Hearing Loss in Observed Non-Growing Vestibular Schwannoma.
Luryi AL; Babu S; Bojrab DI; Kveton JF; Schutt CA
Otol Neurotol; 2022 Aug; 43(7):e767-e772. PubMed ID: 35763454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
